CreatorsPublishersAdvertisers
View more in
Science

Dr. Schjesvold on OCEAN Trial Takeaways With Melflufen in Relapsed/Refractory Myeloma

onclive.com
 2021-09-12

Fredrik Schjesvold, MD, PhD, discusses key takeaways from the phase 3 OCEAN trial that was done in patients with relapsed/refractory multiple myeloma. Fredrik Schjesvold, MD, PhD, founder and leader, Oslo Myeloma Center at Oslo University Hospital, member, International Myeloma Working Group, International Myeloma...

www.onclive.com

Comments / 0

Comments / 0